uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience.
Show others and affiliations
2008 (English)In: Reconstructive Neurosurgery / [ed] Wen-Ta Chiu, Yung-Hsiao Chiang, Ming-Chien Kao et a.-, Wien: Springer , 2008, Vol. 101, 93-98 p.Chapter in book (Other academic)
Abstract [en]

BACKGROUND: We previously demonstrated that exogenous application of bone morphogenetic protein 7 (BMP7) reduced 6-hydroxydopamine-mediated neurodegeneration in a rodent model of Parkinson's disease. The purpose of this study is to examine the endogenous neurotrophic properties of BMP Receptor II in dopaminergic neurons of the nigrostriatal pathway. METHODS: Adult male BMPRII dominant negative (BMPRIIDN) mice and their wild type controls (WT) were placed in the activity chambers for 3 days to monitor locomotor activity. Animals were sacrificed for tyrosine hydroxylase (TH) immunostaining. A subgroup of BMPRIIDN and WT mice were injected with high doses of methamphetamine (MA) and were sacrificed for terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) histochemistry at 4 days after injection. RESULTS: BMPRIIDN mice had lower locomotor activity than the WT. There is a significant decrease in TH neuronal number in substantia nigra compacta, TH fiber density in the substantia nigra reticulata, and TH immunoreactivity in striatum in the BMPRIIDN mice, suggesting that deficiency in endogenous BMP signaling reduces dopaminergic innervation and motor function in the nigrostriatal pathway. Administration of MA increased TUNEL labeling in the substantia nigra in the BMPRIIDN mice. CONCLUSIONS: Endogenous BMPs have trophic effects on nigrostriatal dopaminergic neurons. Deficiency in BMP signaling increases vulnerability to insults induced by high doses of MA.

Place, publisher, year, edition, pages
Wien: Springer , 2008. Vol. 101, 93-98 p.
, Acta Neurochirurgica. Supplementum, ISSN 0065-1419 ; 101
Keyword [en]
Bone morphogenetic protein, BMPRII, methamphetamine, apoptosis
National Category
URN: urn:nbn:se:uu:diva-102573DOI: 10.1007/978-3-211-78205-7_16PubMedID: 18642641ISBN: 978-3-211-78204-0ISBN: 978-3-211-78205-7OAI: oai:DiVA.org:uu-102573DiVA: diva2:216407
Available from: 2009-05-08 Created: 2009-05-08 Last updated: 2010-07-22Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Ebendal, Ted
By organisation
Department of Neuroscience

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 245 hits
ReferencesLink to record
Permanent link

Direct link